[Role of the intestine in the physiopathology of inflammatory rheumatism].

PubWeight™: 0.82‹?›

🔗 View Article (PMID 1411202)

Published in Rev Rhum Mal Osteoartic on June 01, 1992

Authors

D Wendling

Articles by these authors

(truncated to the top 100)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78

ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis (2004) 2.06

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59

Sarcoidosis occuring during anti-TNF-alpha treatment for inflammatory rheumatic diseases: report of two cases. Clin Exp Rheumatol (2008) 1.52

Prospective study of the prevalence of bronchiectasis in rheumatoid arthritis using high-resolution computed tomography. Rev Rhum Engl Ed (1998) 1.43

Spondylodiscitis due to Propionibacterium acnes: report of twenty-nine cases and a review of the literature. Clin Microbiol Infect (2009) 1.41

Rheumatoid arthritis and bronchiectasis. A retrospective study of fourteen cases. Rev Rhum Engl Ed (1996) 1.40

Bilateral frozen shoulder at the same time in two brothers. Rev Rhum Engl Ed (1999) 1.40

Immunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5) Clin Exp Rheumatol (1992) 1.39

Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis. Arthritis Rheum (2001) 1.30

Anterior chest wall malignancies. A review of ten cases. Rev Rhum Engl Ed (1998) 1.21

Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.14

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford) (2002) 1.12

High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol (2003) 1.09

Reactivation of a latent precore mutant hepatitis B virus related chronic hepatitis during infliximab treatment for severe spondyloarthropathy. Ann Rheum Dis (2005) 1.08

Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) (1999) 1.07

Spondylodiscitis in SAPHO syndrome. A series of eight cases. Ann Rheum Dis (1997) 1.06

Eighteen cases of crowned dens syndrome: Presentation and diagnosis. Neurochirurgie (2013) 0.98

Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) (2004) 0.97

Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken) (2012) 0.96

Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) (2001) 0.95

Degenerative spondylolisthesis, synovial cyst of the zygapophyseal joints, and sciatic syndrome: report of two cases and review of the literature. Arthritis Rheum (1988) 0.94

Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann Rheum Dis (2005) 0.93

Relationship between urinary pyridinium cross-links, disease activity and disease subsets of ankylosing spondylitis. Rheumatology (Oxford) (1999) 0.92

Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis (1999) 0.92

TAP1 and TAP2 gene polymorphism in rheumatoid arthritis in a population in eastern France. Eur J Immunogenet (2002) 0.91

Clinical practice decision tree for the choice of the first disease modifying antirheumatic drug for very early rheumatoid arthritis: a 2004 proposal of the French Society of Rheumatology. Ann Rheum Dis (2005) 0.90

Sarcoidosis and spondylarthropathy. Three case-reports. Rev Rhum Engl Ed (1996) 0.90

Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis. Ann Rheum Dis (2000) 0.88

Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol (1997) 0.87

[Bone involvement in primary oxalosis. Study of 20 cases]. Rev Rhum Mal Osteoartic (1991) 0.86

[Osteoporosis in ankylosing spondylitis]. Presse Med (1996) 0.84

[IgA nephropathy and ankylosing spondylitis]. Rev Rhum Mal Osteoartic (1988) 0.84

Lack of association between HLA DRB1* alleles and RS3PE syndrome. Ann Rheum Dis (1998) 0.84

Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry. Ann Rheum Dis (2010) 0.84

Current guidelines for the drug treatment of ankylosing spondylitis. Drugs (1998) 0.83

Pneumococcal polyarticular septic arthritis in a patient with rheumatoid arthritis. Rev Rhum Engl Ed (1999) 0.83

[Chronic polyradiculoneuropathy in a patient with Hodgkin's disease]. Rev Med Interne (2001) 0.82

HLA-DR polymorphism influences T-cell precursor frequencies to Epstein-Barr virus (EBV) gp110: implications for the association of HLA-DR antigens with rheumatoid arthritis. Tissue Antigens (1999) 0.82

Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-up. Rheumatology (Oxford) (2006) 0.82

HLA-DRB1 alleles and shared amino acid sequences in disease susceptibility and severity in patients from eastern France with rheumatoid arthritis. J Rheumatol (1999) 0.82

Safety of surgery after rituximab therapy in 133 patients with rheumatoid arthritis: data from the autoimmunity and rituximab registry. Arthritis Care Res (Hoboken) (2013) 0.81

Intestinal permeability in ankylosing spondylitis. J Rheumatol (1990) 0.81

[The immunogenetics of ankylosing spondylitis]. Rev Med Interne (2006) 0.80

Eruptive pyogenic granulomas and acne fulminans in two siblings treated with isotretinoin. A possible common pathogenesis. Dermatologica (1988) 0.80

The association of HLA-DM genes with rheumatoid arthritis in Eastern France. Hum Immunol (2000) 0.80

Giant calcification in soft tissue after shoulder corticosteroid injection. J Rheumatol (1996) 0.80

Primary biliary cirrhosis and systemic lupus erythematosus. A new case report. Rev Rhum Engl Ed (1998) 0.80

[Bone and visceral manifestations of lipoatrophic diabetes. Apropos of a case]. Rev Rhum Mal Osteoartic (1992) 0.80

From polycystic bone angiomatosis to Gorham's disease. Two case-reports and literature review. Rev Rhum Engl Ed (1998) 0.80

[Articular and periarticular manifestations of chronic hemodialysis in the adult]. Rev Rhum Mal Osteoartic (1986) 0.80

Microcirculation in ankylosing spondylitis. Ann Rheum Dis (1994) 0.79

[Paradoxical cutaneous manifestations during anti-TNF-alpha therapy]. Ann Dermatol Venereol (2009) 0.79

Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis. Br J Rheumatol (1998) 0.79

Rheumatoid arthritis and multiple sclerosis in the same patient. Two case-reports. Rev Rhum Engl Ed (1999) 0.79

Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol (1998) 0.79

Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience. Immunol Rev (1992) 0.78

Transient efficacy of pulse pamidronate treatment in active spondylarthropathies: an open study of 35 cases. Clin Exp Rheumatol (2006) 0.78

Non-radiographic axial spondyloarthritis: what is it? Clin Exp Rheumatol (2013) 0.78

[Infectious osteoarthritis due to Propionibacterium acnes. Two new cases]. Rev Med Interne (2000) 0.78

The B7 cross reactive group and spondyloarthropathies: an epidemiological approach. J Rheumatol (1995) 0.78

Increased frequency of HLA-DRB1*0401 in patients with RA and bronchiectasis. Ann Rheum Dis (2000) 0.78

Crohn's disease associated with seropositive rheumatoid arthritis. Clin Exp Rheumatol (1997) 0.78

Reiter's syndrome induced by Gardnerella vaginalis. Scand J Rheumatol (1998) 0.78

Absence of relation between TGF beta 1 serum levels and bone mass in ankylosing spondylitis patients. Clin Exp Rheumatol (2000) 0.77

HLA DRB1* alleles in rheumatoid nodulosis: a comparative study with rheumatoid arthritis with and without nodules. Rheumatol Int (1998) 0.77

Amyloid arthropathy revealed by RS3PE syndrome. Joint Bone Spine (2000) 0.77

Therapeutic advances in ankylosing spondylitis. Expert Opin Investig Drugs (2001) 0.77

Fibromyalgia developed after administration of gonadotrophin-releasing hormone analogue. Clin Rheumatol (2001) 0.77

Bone metastases from a paraganglioma. A review of five cases. Rev Rhum Engl Ed (1999) 0.77

Combination therapy of anti-CD4 and anti-IL6 monoclonal antibodies in a case of severe spondylarthropathy. Br J Rheumatol (1996) 0.77

Sjögren's syndrome occurring after hepatitis B vaccination. Arthritis Rheum (2000) 0.76

[Hypercalcemia of double origin: association of multiple myeloma and ectopic parathyroidal adenoma]. Rev Med Interne (2007) 0.76

Cyclosporine: a new adjuvant therapy for giant cell arteritis? Arthritis Rheum (1985) 0.76

FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment. Ann Rheum Dis (2005) 0.76

Natural killer cell function in ankylosing spondylitis. Ann Rheum Dis (1988) 0.75

[Rheumatoid synovial cyst of the hip. Apropos of a case]. Rev Rhum Mal Osteoartic (1987) 0.75

Decreased levels of serum soluble HLA class I antigens in HLA-B27 positive spondyloarthropathies. Ann Rheum Dis (2006) 0.75

Calcified synovial cysts of zygapophyseal joints. J Rheumatol (1994) 0.75

Osteolytic Paget's disease of bone under unduly etidronate therapy. Clin Rheumatol (1988) 0.75

[Intramedullary neurinoma. Apropos of a case. Review of the literature]. Neurochirurgie (1992) 0.75

Peripheral primitive neuroectodermal tumors of bone. A review of three cases. Rev Rhum Engl Ed (1999) 0.75

Lack of involvement of the Fas system in ankylosing spondylitis. Ann Rheum Dis (2000) 0.75

Tuberculous rheumatism presenting as spondyloarthropathy. J Rheumatol (1999) 0.75

Vascular purpura and cryoglobulinemia after influenza vaccination. Case-report and literature review. Rev Rhum Engl Ed (1999) 0.75

[Rapidly destructive lumbar spondyloarthropathy in chronic hemodialysis]. Schweiz Med Wochenschr (1992) 0.75

[Radiotherapy in the management of atlantoaxial osteolytic bone metastases]. Presse Med (1993) 0.75

TNF-alpha-targeted therapy in rheumatoid arthritis. Rev Rhum Engl Ed (1999) 0.75

[Unilateral exophthalmos and Wegener's disease]. Rev Med Interne (1991) 0.75

[A new clinical entity: "the algodystrophic intermittent claudication of the lower limbs syndrome" (author's transl)]. Ann Med Interne (Paris) (1981) 0.75

Thalidomide: a comeback? Joint Bone Spine (2000) 0.75

[Polyarthritis accompanying alveolar echinococcosis or the icing on the cake]. Rev Med Interne (2000) 0.75

[Frontal osteoid osteoma]. Rev Rhum Mal Osteoartic (1989) 0.75

[A deformed hand]. Rev Med Interne (1998) 0.75

[Polyarthritis with spinal involvement associated with psoriasis and periodic disease]. Rev Rhum Mal Osteoartic (1983) 0.75

Serum beta 2 microglobulin in ankylosing spondylitis. J Rheumatol (1989) 0.75

Methotrexate-induced hyperpigmentation in a rheumatoid arthritis patient. Clin Exp Rheumatol (2000) 0.75

[Ankylosing spondylarthritis, celiac disease and partial IgA deficiency]. Rev Rhum Mal Osteoartic (1988) 0.75

Skin dimples in hypophosphatasia. Dermatologica (1989) 0.75